Showing results (2961-2970 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|October 29, 2002
Gleevec for the treatment of chronic myelogenous leukemia: US. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug statusMartin H Cohen, Marie L Moses, Richard PazdurThe Oncologist|October 29, 2002
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancerMohammad Jahanzeb, Joanne E Mortimer, Furhan Yunus, et al.The Oncologist|December 20, 2002
Impact of tumor hypoxia and anemia on radiation therapy outcomesLouis B Harrison, Manjeet Chadha, Richard J Hill, et al.The Oncologist|December 20, 2002
A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancerMichael J Guarino, Charles J Schneider, Stephen S Grubbs, et al.The Oncologist|December 20, 2002
Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overviewC M F Kruijtzer, J H Beijnen, J H M SchellensThe Oncologist|May 30, 2003
Clinical application of cDNA microarrays in oncologyLajos Pusztai, Mark Ayers, James Stec, et al.The Oncologist|October 25, 2001
Activity of infusional etoposide, vincristine, and doxorubicin with bolus cyclophosphamide (EPOCH) in relapsed Hodgkin's diseaseC T Stokoe, J Ogden, V K JainThe Oncologist|October 25, 2001
Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemiaJ Hounshell, C Tomori, R Newlin, et al.The Oncologist|November 9, 2001
Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignanciesA F ListPageof 571